Free Trial

Telesis Bio (TBIO) Competitors

Telesis Bio logo
$0.47 -0.09 (-16.07%)
(As of 12/20/2024 03:47 PM ET)

TBIO vs. TLIS, SPEC, THMO, OLITW, PRENW, QSIAW, SMAPW, TT, KEYS, and FTV

Should you be buying Telesis Bio stock or one of its competitors? The main competitors of Telesis Bio include Talis Biomedical (TLIS), Spectaire (SPEC), ThermoGenesis (THMO), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), Trane Technologies (TT), Keysight Technologies (KEYS), and Fortive (FTV). These companies are all part of the "measuring and control equipment" industry.

Telesis Bio vs.

Telesis Bio (NASDAQ:TBIO) and Talis Biomedical (NASDAQ:TLIS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their community ranking, dividends, earnings, risk, profitability, media sentiment, analyst recommendations, institutional ownership and valuation.

Telesis Bio has higher revenue and earnings than Talis Biomedical. Talis Biomedical is trading at a lower price-to-earnings ratio than Telesis Bio, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Telesis Bio$225.09M0.00-$47.72M-$28.20-0.02
Talis Biomedical$300K10.50-$62.01M-$28.02-0.06

Telesis Bio has a net margin of -336.59% compared to Talis Biomedical's net margin of -5,784.73%. Talis Biomedical's return on equity of -79.74% beat Telesis Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
Telesis Bio-336.59% -359.32% -61.89%
Talis Biomedical -5,784.73%-79.74%-57.16%

Telesis Bio and Talis Biomedical both received 9 outperform votes by MarketBeat users. However, 52.94% of users gave Telesis Bio an outperform vote while only 37.50% of users gave Talis Biomedical an outperform vote.

CompanyUnderperformOutperform
Telesis BioOutperform Votes
9
52.94%
Underperform Votes
8
47.06%
Talis BiomedicalOutperform Votes
9
37.50%
Underperform Votes
15
62.50%

Telesis Bio has a beta of 1.58, meaning that its share price is 58% more volatile than the S&P 500. Comparatively, Talis Biomedical has a beta of 1.58, meaning that its share price is 58% more volatile than the S&P 500.

37.6% of Telesis Bio shares are owned by institutional investors. Comparatively, 43.8% of Talis Biomedical shares are owned by institutional investors. 24.5% of Telesis Bio shares are owned by company insiders. Comparatively, 46.0% of Talis Biomedical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Telesis Bio's average media sentiment score of 0.00 equaled Talis Biomedical'saverage media sentiment score.

Company Overall Sentiment
Telesis Bio Neutral
Talis Biomedical Neutral

Summary

Talis Biomedical beats Telesis Bio on 6 of the 11 factors compared between the two stocks.

Get Telesis Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for TBIO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TBIO vs. The Competition

MetricTelesis BioAnalytical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$994,000.00$5.42B$5.14B$9.08B
Dividend YieldN/A0.43%5.09%4.23%
P/E Ratio-0.0225.1890.1317.20
Price / Sales0.004.291,117.09117.04
Price / CashN/A44.4543.1037.85
Price / Book3.362.204.784.78
Net Income-$47.72M$2.05M$120.31M$225.60M
7 Day Performance17.50%-2.70%-1.92%-1.23%
1 Month Performance-48.35%-4.22%13.65%0.46%
1 Year Performance-93.30%-29.70%28.34%15.24%

Telesis Bio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TBIO
Telesis Bio
N/A$0.47
-16.1%
N/A-92.5%$994,000.00$225.09M-0.02200
TLIS
Talis Biomedical
N/A$1.70
-0.6%
N/A-78.5%$3.09M$2.13M-0.06260
SPEC
Spectaire
N/A$0.02
+12.4%
N/A-99.0%$350,000.00N/A0.008Gap Up
THMO
ThermoGenesis
N/A$0.00
flat
N/A-99.9%$4,000.00$9.61M0.0025
OLITW
OmniLit Acquisition
N/A$0.08
+33.3%
N/A+104.0%$0.00N/A0.003Gap Up
High Trading Volume
PRENW
Prenetics Global
N/A$0.01
-17.2%
N/AN/A$0.00$25.56M0.001Positive News
Gap Down
QSIAW
Quantum-Si
N/A$0.47
+10.1%
N/A+79.4%$0.00$2.27M0.00159Gap Up
High Trading Volume
SMAPW
SportsMap Tech Acquisition
N/A$0.02
+1.6%
N/AN/A$0.00N/A0.00N/AGap Up
TT
Trane Technologies
4.0789 of 5 stars
$398.68
-0.2%
$409.93
+2.8%
+54.9%$89.71B$19.39B37.0540,000Positive News
KEYS
Keysight Technologies
4.8394 of 5 stars
$171.00
+2.7%
$180.80
+5.7%
+2.8%$29.68B$4.98B49.0414,900Analyst Revision
FTV
Fortive
4.7344 of 5 stars
$76.76
-0.1%
$86.73
+13.0%
+2.6%$26.63B$6.20B30.5518,000Analyst Forecast

Related Companies and Tools


This page (NASDAQ:TBIO) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners